Anlit has been granted GMP certification by the Australian Therapeutic Goods Administration (TGA), the governmental authority charged with regulating therapeutic goods for the protection of public health and safety. The certification was granted to Anlit’s Kidi Bites, an innovative supplement format designed specifically for children.
The TGA is world-renowned for its high standards of quality, requiring food supplement producers to conform with the rigorous requirements imposed on pharmaceutical production.
“Anlit approached this certification as a strategic move, designed to bring our products to the global forefront of quality and excellence,” says Shai Karlinski, Marketing VP for Anlit. “Anlit had to follow a fast learning curve, forging beyond the former food supplement paradigms and adopting new pharma concepts and processes.”
Attaining the TGA stamp of approval is part of Anlit’s strategy for pursuing the highest and most stringent quality standards, paving the way to partnerships with global pharmaceutical companies that are seeking diversification of their product portfolio with unique food supplements. “Thanks to this important certification, Sanofi Aventis, Australia, just launched two of our innovative Kidi Bites supplements for children — Multivitamin and Calcium — in Australia,” notes Karlinski.
Anlit’s Kidi Bites Technology produces tasty supplements focused on kids’ preferences and providing the essential health benefits children need. The delicious matrix, with chocolaty flavor and texture, overcomes children’s typical reluctance to taking nutritional supplements.